Emerging therapies for the treatment of neovascular age related macular degeneration (Q37879168)

24 August 2017

1 reference

title

Emerging therapies for the treatment of neovascular age related macular degeneration (English)

1 reference

24 August 2017

Alex Yuan

1

1 reference

24 August 2017

Peter K Kaiser

series ordinal

2

1 reference

24 August 2017

language of work or name

English

0 references

publication date

1 May 2011

1 reference

Seminars in Ophthalmology

24 August 2017

published in

1 reference

24 August 2017

volume

26

1 reference

24 August 2017

issue

3

1 reference

24 August 2017

page(s)

149-155

1 reference

Prevalence of age-related macular degeneration in the United States

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2011.570846

Causes and prevalence of visual impairment among adults in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2011.570846

Ranibizumab for neovascular age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2011.570846

Ranibizumab versus verteporfin for neovascular age-related macular degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2011.570846

Vascular endothelial growth factor: basic science and clinical progress

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2011.570846

Defining the role of mTOR in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2011.570846

A randomized pilot study of systemic immunosuppression in the treatment of age-related macular degeneration with choroidal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2011.570846

Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2011.570846

VEGF/VEGFR signalling as a target for inhibiting angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2011.570846

Tumorigenesis and the angiogenic switch

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2011.570846

Pigment epithelium-derived factor is deficient in the vitreous of patients with choroidal neovascularization due to age-related macular degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2011.570846

Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2011.570846

Adenoviral vector-delivered pigment epithelium-derived factor for neovascular age-related macular degeneration: results of a phase I clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2011.570846

Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2011.570846

Blockade of sphingosine-1-phosphate reduces macrophage influx and retinal and choroidal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2011.570846

Mecamylamine suppresses Basal and nicotine-stimulated choroidal neovascularization.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2011.570846

Requirement of vascular integrin alpha v beta 3 for angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2011.570846

Uniform overexpression and rapid accessibility of alpha5beta1 integrin on blood vessels in tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2011.570846

Fibronectin fragments promote human retinal endothelial cell adhesion and proliferation and ERK activation through alpha5beta1 integrin and PI 3-kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2011.570846

Consequences of lack of beta 1 integrin gene expression in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2011.570846

Preclinical evaluation of the novel small-molecule integrin alpha5beta1 inhibitor JSM6427 in monkey and rabbit models of choroidal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2011.570846

Assessment of the integrin alpha5beta1 antagonist JSM6427 in proliferative vitreoretinopathy using in vitro assays and a rabbit model of retinal detachment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2011.570846

Pericyte Loss and Microaneurysm Formation in PDGF-B-Deficient Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2011.570846

Inhibition of platelet-derived growth factor B signaling enhances the efficacy of anti-vascular endothelial growth factor therapy in multiple models of ocular neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2011.570846

Combretastatin A-4 phosphate suppresses development and induces regression of choroidal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2011.570846

The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2011.570846

Pathway-based therapies for age-related macular degeneration: an integrated survey of emerging treatment alternatives

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2011.570846

10.3109/08820538.2011.570846

21 January 2018

Identifiers

DOI

1 reference

24 August 2017

1 reference